Home > Financial Ratios > SUN PHARMA ADVANCED RESEARCH COMPANY

SUN PHARMA ADVANCED RESEARCH COMPANY
Core EBITDA Margin

    Back to All Ratios
SUN PHARMA ADVANCED RESEARCH COMPANY is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SUN PHARMA ADVANCED RESEARCH COMPANY
Please provide your vote to see the results

SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2024Mar2023
   Core EBITDA Margin(%) -532.26-89.65

What is the latest Core EBITDA Margin ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?

The latest Core EBITDA Margin ratio of SUN PHARMA ADVANCED RESEARCH COMPANY is -532.26 based on Mar2024 Consolidated results.
Year Core EBITDA Margin
Mar2024-532.26
Mar2023-89.65

How is Core EBITDA Margin of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?

Years Core EBITDA Margin % Change
Mar2024 -532.26
Negative
Mar2023 -89.65 -

Other Financial Ratios of SUN PHARMA ADVANCED RESEARCH COMPANY


Compare Core EBITDA Margin ratio of peers of SUN PHARMA ADVANCED RESEARCH COMPANY

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUN PHARMA ADVANCED RESEARCH COMPANY ₹5,089.8 Cr -1.8% -4% -32.8% Stock Analytics
SYNGENE INTERNATIONAL ₹25,598.7 Cr -2.2% -0.3% -11.1% Stock Analytics
SAGILITY INDIA ₹18,865.8 Cr -1.9% -5.1% NA Stock Analytics
LATENT VIEW ANALYTICS ₹8,421.1 Cr 1% -2.1% -19.1% Stock Analytics
JUST DIAL ₹7,393.8 Cr -1.3% -6.4% -12.2% Stock Analytics
AWFIS SPACE SOLUTIONS ₹4,730.0 Cr 0.7% 2.2% 31% Stock Analytics


SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SUN PHARMA ADVANCED RESEARCH COMPANY

-1.8%

-4%

-32.8%

SENSEX

0.1%

1.2%

6%


You may also like the below Video Courses